Skip to content
Buy This GLP
← Research
Formats

What Is Elecoglipron? Trial Results and Phase 3 Status

Elecoglipron is an investigational oral GLP-1 drug. Phase 2 VISTA measured weight change over 36 weeks, and phase 3 trials are underway.

Editorial profile: Neil SandersBuy This GLP Editorial Team3 min read
Body weight lost at week 26, obesity trial75 mg−10.5%5 mg−2.6%placebo−0.6%A daily tablet in phase 2. Not approved, not for sale.310 adults with obesity or overweight, no diabetes.

Among GLP-1 pills in development, elecoglipron is an investigational small molecule that activates the GLP-1 receptor. AstraZeneca reported ongoing phase 3 trials in its November 2026 update [2].

What the phase 2 trial found

VISTA randomized 310 adults with obesity or overweight and a related condition [1]. In one 75 mg study group, the efficacy analysis estimated 10.5% weight loss at 26 weeks. The placebo estimate was 0.6%.

At 36 weeks, the same analysis estimated 11.8% weight loss in that group and 0.3% with placebo. The efficacy analysis estimated results if participants stayed on the assigned treatment. VISTA did not compare elecoglipron with other weight-loss drugs.

How it differs from an approved pill

Elecoglipron remains investigational. The FDA approved a different oral small molecule, orforglipron (Foundayo), for weight management in April 2026 [3]. The drugs have separate trials and regulatory records.

Frequently asked

Is elecoglipron FDA-approved?
Elecoglipron remains in clinical development. Foundayo is the brand name of orforglipron, a different medicine.

Sources

  1. [1] Davies MJ, et al. (2026). Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial The Lancet. Source
  2. [2] AstraZeneca (2026). Post-Q3 2026 aide memoire AstraZeneca. Source
  3. [3] U.S. Food and Drug Administration (2026). FDA Approves First New Molecular Entity Under National Priority Voucher Program FDA. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Formats